Global Autoimmune Disease Diagnosis Market is estimated to be 6.3 Billion by 202Posted by NISHA SHAHA on December 2nd, 2021 The global autoimmune disease diagnostics market is driven by growth in public awareness for autoimmune disorders, improved laboratory techniques and automation, growth in partnerships between clinical laboratories and physicians, rise in incidence of diseases such as Graves and Hashimoto\'s Thyroid Disease and rheumatoid arthritis. The global autoimmune disease diagnosis market accounted for US$ 4.1 billion in 2020 and is estimated to be 6.3 billion by 2025 and is anticipated to register a CAGR of 7.5%. The report. \"Global Autoimmune Disease Diagnosis Market, By Product (Consumables & Assay Kits and Instruments), By Test Type (Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test, and Other Tests), By Disease (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, and Other Diseases), By End User (Clinical Laboratories, Hospitals, and Other End Users), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”. Key Highlights:
Analyst View: Growing awareness about autoimmune diseases Growing awareness about autoimmune diseases through programs of education, research, support, and advocacy is a key factor driving the utilized rates of autoimmune disease diagnostics, worldwide. The U.S. has the highest prevalence’s of autoimmune diseases, whereas around 50 million patients suffer from autoimmune diseases. According to study reported by Arthritis Foundation, in 2017 nearly 54.4 million adults in the U.S. suffer from diagnosed arthritis. According to the International Diabetes Federation (IDF) report of the 2017, around 425 million adults (20-79 years) were suffering from diabetes, and by 2045 this number might increase to 629 million, across the globe. NGOs and government organizations aims to increase awareness about the socioeconomic impact of autoimmunity by driving and facilitating collaboration in the areas of education, research, public awareness, and patient services in an ethical, efficient, and effective manner. The other factors, such as partnerships with physicians and clinical laboratories, improved laboratory automation, and technological advancements, are fueling the autoimmune disease diagnostics market. Increasing collaboration between market players The growing partnerships between companies involved in autoimmune disease diagnostics market is useful for technology transfer, thereby increasing the availability of diagnostic systems. For example in 2015, Sengenics acquired Oxford Gene Technology’s protein array technology. This acquisition was useful in the diagnosis of various autoimmune conditions. Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Autoimmune Disease Diagnosis Market”, By Product (Consumables & Assay Kits and Instruments), By Test Type (Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test, and Other Tests), By Disease (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, and Other Diseases), By End User (Clinical Laboratories, Hospitals, and Other End Users), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030 Key Market Insights from the report: The global autoimmune disease diagnosis market accounted for US$ 4.1 billion in 2020 and is estimated to be 6.3 billion by 2025 and is anticipated to register a CAGR of 7.5%. The market report has been segmented on the basis of product, test type, disease, end-user, and region.
To know the upcoming trends and insights prevalent in this market, click the link below: Competitive Landscape: The prominent player operating in the global autoimmune disease diagnosis market includes Thermo Fisher Scientific, Siemens Healthcare Private Limited, Hoffmann-La Roche Ltd., Abbott Laboratories, Beckman Coulter, Inc., SQI Diagnostics Inc., Quest Diagnostics, EUROIMMUN AG, INOVA Diagnostics, Inc., and Bio-Rad Laboratories, Inc. The market provides detailed information regarding industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory framework across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included into the report. About Prophecy Market Insights Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business. Some Important Points Answered in this Market Report Are Given Below:
Key Topics Covered
To know more Contact Us: Sales Prophecy Market Insights Like it? Share it!More by this author |